Get startedLog in
    Picture of Perspective Therapeutics logo

    CATX — Perspective Therapeutics Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Perspective Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2019
    June 30th
    2020
    June 30th
    2021
    June 30th
    2022
    June 30th
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-5.14-3.45-3.39-7.27-46.5
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items0.4270.4550.4311.128.96
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-0.518-0.835-0.067-1.852.3
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Cash from Operating Activities-5.05-3.64-2.84-7.71-36.9
    Capital Expenditures-0.458-0.287-0.411-0.284-1.09
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.85900.001025.5
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Cash from Investing Activities0.401-0.287-0.41-0.28424.4
    Financing Cash Flow Items————-0.065
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities7.370.99464.70.0560.785
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash2.73-2.9361.4-7.94-11.8